Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,964 Cardiology
clinical trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
The Cancer Center of Hawaii-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital-Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Union County
mi
from
New Albany, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Hospital Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Opthea Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Opthea Investigative Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates of NEA
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Left Ventricular Dysfunction Clinical Trial
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Status: Enrolling
Updated: 12/31/1969
St Elizabeth Youngstown Hospital
mi
from
Youngstown, OH
Click here to add this to my saved trials
Single Ventricle Heart Disease Clinical Trial
Evaluation of Fontan-Associated Liver Disease
Status: Enrolling, Phase
Updated: 12/31/1969
University of Nebraska Children's Hospital and Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Single Ventricle Heart Disease Clinical Trial
Evaluation of Fontan-Associated Liver Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
Status: Enrolling, Phase IV
Updated: 12/31/1969
Anderson Orthopaedic Institute (VA)
mi
from
Alexandria, VA
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling, Phase IV
Updated: 12/31/1969
Family Medicine at Hampton Oaks Medical Plaza (Adults and Peds)
mi
from
Gainesville, FL
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Status: Enrolling, Phase IV
Updated: 12/31/1969
Cardiology West at Doctors Park
mi
from
Gainesville, FL
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Beth Israel Deaconess Medical
mi
from
Boston, MA
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
New York-Presbyterian/Brooklyn Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
OSU Wexner
mi
from
Columbus, OH
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Herman
mi
from
Houston, TX
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Bruce W. Carter VA
mi
from
Miami, FL
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
WVU Healthcare Ruby Memorial
mi
from
Morgantown, WV
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
UT Health Sciences San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Stroke Clinical Trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Enrolling, Phase III
Updated: 12/31/1969
Sharp Grossmont
mi
from
San Diego, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Status: Enrolling, Phase IV
Updated: 12/31/1969
Austin Heart Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Without Rupture Clinical Trial
EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study
Status: Enrolling
Updated: 12/31/1969
Midwest Aortic Vascular Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Hemodynamic-GUIDEd Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Group Cardiology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Hemodynamic-GUIDEd Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
St. Cloud Hospital
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Hemodynamic-GUIDEd Management of Heart Failure
Status: Enrolling
Updated: 12/31/1969
Main Line Health Center/Lankenau Hospital
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Lukes Idaho Cardiology Associates
mi
from
Boise, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Status: Enrolling, Phase III
Updated: 12/31/1969
Rama Research LLC
mi
from
Marion, OH
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Connecticut Health Network
mi
from
Danbury, CT
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
Pharmacology Research, LLC
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
The Center for Clinical Trials, Inc.
mi
from
Saraland, AL
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
Manshadi Heart Institute Inc
mi
from
Stockton, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California Los Angeles
mi
from
Torrance, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Status: Enrolling, Phase III
Updated: 12/31/1969
Georgia Arrhythmia Consultants and Research Institute
mi
from
Warner Robins, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Rheumatology, Orthopedics / Podiatry Clinical Trial
Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology
Status: Enrolling, Phase
Updated: 12/31/1969
Attune Health
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
Trinity Medical WNY, PC
mi
from
Buffalo, NY
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Side Branch FFR After Provisional Stenting
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai and Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Center for Dermatology
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
Status: Enrolling, Phase III
Updated: 12/31/1969
Laser & Skin Surgery Center of New York (LSSCNY)
mi
from
New York, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gurnee, IL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tupelo, MS
Click here to add this to my saved trials
Heart Failure Clinical Trial
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waterbury, CT
Click here to add this to my saved trials
Heart Failure Clinical Trial
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
Tricuspid Regurgitation Clinical Trial
Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Nephrology / Urology, Other Clinical Trial
VasQ External Support for Arteriovenous Fistula
Status: Enrolling
Updated: 4/18/2018
Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
PARTNER 3 Trial - Mitral Valve in Valve
Status: Enrolling
Updated: 12/31/1969
Morristown Medical Center / Atlantic Health System Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Non-obstructive Hypertrophic Cardiomyopathy Clinical Trial
A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Medicine
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Obstructive Hypertrophic Cardiomyopathy Clinical Trial
Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Penn State Health Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Obstructive Hypertrophic Cardiomyopathy Clinical Trial
Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic Jacksonville - PPDS
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
Status: Enrolling, Phase II
Updated: 12/31/1969
Penrose St. Francis Health Services
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
Status: Enrolling, Phase II
Updated: 12/31/1969
Grace Research, LLC
mi
from
Huntsville, TX
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
Status: Enrolling, Phase II
Updated: 12/31/1969
Carolina Heart Specialists
mi
from
Lancaster, SC
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
Status: Enrolling, Phase II
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
ANTHEM-HFrEF Pivotal Study
Status: Enrolling
Updated: 12/31/1969
UnityPoint Health
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Benefits of µCor in Ambulatory Decompensated Heart Failure
Status: Enrolling
Updated: 12/31/1969
South Palm Cardiovascular Research Institute
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Benefits of µCor in Ambulatory Decompensated Heart Failure
Status: Enrolling
Updated: 12/31/1969
Holy Cross Medical Group
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Benefits of µCor in Ambulatory Decompensated Heart Failure
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Institute of Central Florida
mi
from
Ocala, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomization of Single vs Multiple Arterial Grafts
Status: Enrolling
Updated: 12/31/1969
Weil Cornell Medical College Department of Cardiothoracic Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections
Status: Enrolling, Phase
Updated: 12/31/1969
MidAtlantic Retina
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Status: Enrolling
Updated: 12/31/1969
Princeton Baptist Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
New Albany, IN
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Paducah, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Standardizing Emergency Work-ups Around Risk Data
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente Fremont Emergency Department
mi
from
Fremont, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Standardizing Emergency Work-ups Around Risk Data
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente San Rafael Emergency Department
mi
from
San Rafael, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology, Psychiatry / Psychology Clinical Trial
Early Psychological Intervention to Prevent Cardiovascular Event-Induced PTSD (REACH Sub-study)
Status: Enrolling
Updated: 12/31/1969
Center for Behavioral Cardiovascular Health
mi
from
New York, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders and Previously Untreatable Patients (SOLVE CRT)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Prince Charles Hospital
mi
from
Chermside,
Click here to add this to my saved trials
Heart Failure Clinical Trial
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
Status: Enrolling, Phase III
Updated: 12/31/1969
Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Coronary Artery Disease (CAD) Clinical Trial
An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
Status: Enrolling, Phase III
Updated: 12/31/1969
V.A St. Louis Health Care System
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cambridge, MA
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Muncie, IN
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sayre, PA
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stockton, CA
Click here to add this to my saved trials
Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wellington, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Feasibility Study of the AccuCinch® Ventricular Repair System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
Status: Enrolling
Updated: 12/31/1969
Virginia Tech Carilion School of Medicine and Research Institute
mi
from
Roanoke, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
National Cardiogenic Shock Initiative
Status: Enrolling, Phase
Updated: 12/31/1969
Ellis Hospital
mi
from
Schenectady, NY
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
USC Roski Eye Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Center Northwest
mi
from
Silverdale, WA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Prairie Eye Center, Ltd. | Prairie Retina Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Florida Health
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic™
Status: Enrolling, Phase
Updated: 12/31/1969
Cardiology Physicians PA
mi
from
Newark, DE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases, Orthopedics / Podiatry Clinical Trial
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Piedmont Healthcare Pulmonary and Critical Care Research
mi
from
Austell, GA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ames, IA
Click here to add this to my saved trials